 | Minerva Neurosciences Inc (NASDAQ:NERV) Sees Large Increase in Short Interest
www.americanbankingnews.com - July 5 at 7:38 PM |
| Minerva Neurosciences (NASDAQ:NERV) Receives Buy Rating from HC Wainwright
www.americanbankingnews.com - July 3 at 8:29 AM |
| Minerva Neurosciences' (NERV) "Buy" Rating Reaffirmed at JMP Securities
www.americanbankingnews.com - July 3 at 7:50 AM |
| Minerva Neurosciences (NASDAQ:NERV) Given "Hold" Rating at William Blair
www.americanbankingnews.com - July 2 at 3:58 PM |
 | BRIEF-Minerva Neurosciences Exercises Right To Opt Out Of Agreement With Janssen For Seltorexant
www.reuters.com - July 2 at 12:42 AM |
 | Minerva Neurosciences, Inc: Minerva Neurosciences Exercises Right to Opt Out of Agreement With Janssen for Seltorexant (MIN-202)
www.finanznachrichten.de - July 1 at 9:40 AM |
 | Minerva Neurosciences Exercises Right to Opt Out of Agreement With Janssen for Seltorexant (MIN-202)
finance.yahoo.com - July 1 at 9:40 AM |
| Zacks: Analysts Expect Minerva Neurosciences Inc (NASDAQ:NERV) to Post -$0.37 EPS
www.americanbankingnews.com - July 1 at 3:42 AM |
| Minerva Neurosciences Inc (NASDAQ:NERV) Given Consensus Recommendation of "Buy" by Analysts
www.americanbankingnews.com - June 26 at 6:14 AM |
 | Do Options Traders Know Something About Minerva Neurosciences (NERV) Stock We Don't?
www.nasdaq.com - June 22 at 2:27 PM |
|
| Do Options Traders Know Something About Minerva Neurosciences (NERV) Stock We Don't?
finance.yahoo.com - June 22 at 9:27 AM |
| NERV Minerva Neurosciences, Inc Common Stock
www.nasdaq.com - June 21 at 6:23 PM |
| Short Interest in Minerva Neurosciences Inc (NASDAQ:NERV) Grows By 20.2%
www.americanbankingnews.com - June 19 at 2:49 PM |
 | Global Insomnia Medication Market2020Production, Revenue, Price and Gross Margin Analysis with Forecasts to 2026
www.marketwatch.com - June 7 at 2:33 PM |
| Minerva Neurosciences (NERV) Looks Good: Stock Adds 8.4% in Session
finance.yahoo.com - June 5 at 2:40 PM |
| How Minerva Neurosciences (NERV) Stock Stands Out in a Strong Industry
finance.yahoo.com - June 2 at 1:45 PM |
| Why Minerva Neurosciences Is Heading Higher Today
finance.yahoo.com - June 1 at 2:28 PM |
| REVISED WEBCAST & CALL INFORMATION: Minerva Neurosciences to Hold Webcast and Call With Key Opinion Leaders to Present Additional Analyses From Phase 3 Trial of Roluperidone (MIN-101) for Treatment of Negative Symptoms in Schizophrenia
finance.yahoo.com - June 1 at 9:27 AM |
| Minerva Shares Tank 72% As Schizophrenia Drug Misses Trial Goals
finance.yahoo.com - May 31 at 8:02 AM |
| BRIEF-Minerva Neurosciences Announces Results From Phase 3 Trial Of Roluperidone (Min-101) For Treatment Of Negative Symptoms In Schizophrenia
www.reuters.com - May 29 at 11:26 PM |
| Here's Why Minerva Neurosciences Collapsed Today
finance.yahoo.com - May 29 at 6:21 PM |
| Minerva Neurosciences' schizophrenia drug misses main goal in study
www.reuters.com - May 29 at 1:20 PM |
| Minerva Schizophrenia-Drug Trial Misses Key Endpoints
finance.yahoo.com - May 29 at 1:20 PM |
| Notable Tuesday Option Activity: NERV, TSLA, FB
www.nasdaq.com - May 26 at 7:05 PM |
| Edited Transcript of NERV earnings conference call or presentation 4-May-20 12:30pm GMT
finance.yahoo.com - May 25 at 6:46 PM |
 | Momentum investing with Minerva Neurosciences Inc (NMQ:NERV)
uk.finance.yahoo.com - May 22 at 11:46 AM |
 | Thinking about trading stocks or options in Moderna, Carnival Corp, Minerva Neurosciences, Apple, or Nvidia?
www.prnewswire.com - May 14 at 12:43 PM |
| Top Ranked Momentum Stocks to Buy for May 11th
finance.yahoo.com - May 11 at 3:28 PM |
|
| BRIEF-Minerva Neurosciences Reports First Quarter 2020 Financial Results
www.reuters.com - May 4 at 9:12 PM |
| Minerva Neurosciences Inc (NERV) Q1 2020 Earnings Call Transcript
finance.yahoo.com - May 4 at 9:12 PM |
 | Minerva Neurosciences, Inc. (NERV) CEO Remy Luthringer on Q1 2020 Results - Earnings Call Transcript
seekingalpha.com - May 4 at 4:11 PM |
| Minerva Neurosciences, Inc: Minerva Neurosciences Reports First Quarter 2020 Financial Results and Business Updates
www.finanznachrichten.de - May 4 at 8:49 AM |
| Minerva Neurosciences Reports First Quarter 2020 Financial Results and Business Updates
finance.yahoo.com - May 4 at 8:49 AM |
| Minerva Neurosciences to Report First Quarter 2020 Financial Results and Business Updates on May 4, 2020
finance.yahoo.com - April 27 at 11:25 AM |
 | Minerva Neurosciences, Inc: Minerva Neurosciences Reports First Quarter 2019 Financial Results and Business Updates
www.bloomberg.com - April 22 at 9:04 AM |
| Minerva Neurosciences, Inc: Minerva Neurosciences Announces Completion of Patient Enrollment in Phase 3 Trial of Roluperidone
www.bloomberg.com - April 21 at 1:02 PM |
| Minerva Neurosciences, Inc. (NASDAQ:NERV): What Does Its Beta Value Mean For Your Portfolio?
finance.yahoo.com - April 20 at 3:12 PM |
| Edited Transcript of NERV earnings conference call or presentation 9-Mar-20 12:30pm GMT
finance.yahoo.com - March 27 at 8:02 AM |
| MINERVA NEUROSCIENCES TO HOST KEY OPINION LEADER MEETING ON ROLUPERIDONE: A POTENTIALLY NOVEL MECHANISM TO TREAT THE NEGATIVE SYMPTOMS OF SCHIZOPHRENIA
finance.yahoo.com - March 24 at 12:08 PM |
| Are Options Traders Betting on a Big Move in Minerva Neurosciences (NERV) Stock?
finance.yahoo.com - March 19 at 1:12 PM |
| MINERVA NEUROSCIENCES UPDATES MARKET ON SHARE PRICE DROP AND TRADING HALT
finance.yahoo.com - March 12 at 7:44 PM |
| Minerva Neurosciences Inc (NERV) Q4 2019 Earnings Call Transcript
www.nasdaq.com - March 9 at 5:53 PM |
| BRIEF-Minerva Neurosciences Posts Q4 loss per share of $0.77
www.reuters.com - March 9 at 12:53 PM |
| Minerva Neurosciences EPS misses by $0.39
seekingalpha.com - March 9 at 7:52 AM |
| Minerva Neurosciences, Inc. to Host Earnings Call
finance.yahoo.com - March 9 at 7:52 AM |
| Minerva Neurosciences Reports Fiscal 2019 Fourth Quarter and Year End Financial Results and Business Updates
finance.yahoo.com - March 9 at 7:52 AM |
| Minerva Neurosciences to Report Fiscal 2019 Fourth Quarter and Year End Financial Results and Business Updates on March 9, 2020
finance.yahoo.com - March 2 at 9:07 AM |
| Minerva Neurosciences to Host Key Opinion Leader Meeting on Avolition, the Most Central Domain for the Successful Treatment of Negative Symptoms in Schizophrenia
finance.yahoo.com - February 28 at 3:06 PM |
| Who Has Been Buying Minerva Neurosciences, Inc. (NASDAQ:NERV) Shares?
finance.yahoo.com - February 17 at 2:39 PM |
| Minerva Neurosciences, Inc.: Minerva Neurosciences Names Richard Russell President
www.bloomberg.com - February 14 at 7:55 PM |
